8 – 9 September 2018 | Hilton Hotel Kuala Lumpur

• Controversial topics and stimulating science

S A V E T H E D A T E

• Leading international experts

• Clinical trial updates and pipeline

• Live interaction of audience using digital tools

SYMPOSIUM ON THE CONCEPTS &CONTROVERSIES IN HEART FAILURE

For Healthcare Professionals Only

ACCREDITATIONw

ill be accredited

CME Points

H of the

Novartis Corporation (Malaysia) Sdn Bhd (10920H)

Level 22, Tower B, Plaza 33, No. 1, Jalan Kemajuan, Seksyen 13, 46200 Petaling Jaya, Selangor Darul EhsanTel : +603 7948 1888 Fax: +603 7948 1818 Website: www.novartis.com HO

M.IN

V.0

1/M

Y18

0583

4114

For RSVP: Kindly contact, Mr Reinus HiewMobile: +6017 260 3977, Email: hotm2@platinumpodium.com.my

AGENDA: DAY 2 9 September 2018

SYMPOSIUM ON THE CONCEPTS &CONTROVERSIES IN HEART FAILURE

8 – 9 September 2018 | Hilton Hotel Kuala Lumpur

For Healthcare Professionals Only

H of the

0715 – 0800

0800 – 0915

0915 – 0940

0940 – 1005

1005 – 1030

1030 – 1055

1055 – 1115

1115 – 1140

1140 – 1205

1205 – 1230

1230 – 1255

1255 – 1320

1320 – 1335

1335 – 1340

Breakfast and Registration

Session I: Optimizing Heart Failure Services

HF Clinic Workshop: A Multidisciplinary Approach

Session II: CHF and AHF – Navigating the Challenges

How to Improve Time to First Diagnosis in AHF?

Complexities of Heart Failure – What the Heart Failure Guidelines Did and Didn’t Tell Us

Ischemic Cardiomyopathy – Revascularization or HF Therapy First?

Panel Q&A Session

Coffee/ Tea Break

Managing Diabetes and Renal Impairment in Heart Failure

HF with Preserved Ejection Fraction – Is there a Key Mechanism?

A Rude Awakening: Sleep Apnoea and HF (CPAP Controversy)

Biomarkers in Heart Failure – Who’s Hot and Who’s Not

Much Ado about Heart Failure Prognostic Models: To Score or Not to Score?

Panel Q&A Session

Summary and Closing Remarks

Lunch Break & Networking

TIME SESSION

AGENDA: DAY 1 8 September 2018

0830 – 0920

0920 – 0930

0930 – 0950

0950 – 1020

1020 – 1040

1040 – 1110

1110 – 1140

1140 – 1155

1155 – 1220

1220 – 1245

1245 – 1310

1310 – 1335

1335 – 1350

1350 – 1450

1450 – 1515

1515 – 1540

1540 – 1605

1605 – 1630

1630 – 1645

1645 – 1700

1700 – 1715

1715 – 1730

1730 – 1745

1745 – 1815

1815 – 1830

1830 – 1845

1845 – 2000

Breakfast and Registration

Welcome and Introduction

Session IA: Treatment of Chronic Heart Failure (Part 1)

De�nition & Algorithm for a Diagnosis of Chronic Heart Failure

PARADIGM-HF Trial – Taking a Closer Look at Special Populations

Coffee/ Tea Break

What have we Learned since the Publication of PARADIGM-HF

The Conundrum of the Stable Heart Failure Patient

Panel Q&A Session

Session IB: Treatment of Chronic Heart Failure (Part 2)

Cardiac Resynchronization Therapy: A Review of Evidence

Sudden Cardiac Death in CCF Patients

Mitral and Tricuspid Regurgitation in HF – A Surgical Perspective

Mechanical Circulatory Support: LVADs & Heart Transplantation: Now and in the Future

Panel Q&A session

Lunch

Session II: Challenging Cases In Chronic Heart Failure

Co-morbidities in Chronic Heart Failure

‘Stable’ Heart Failure Patient – Can You Believe What You See?

Advanced Heart Failure

HF with AF: Vicious Twins

Panel Q&A Session

Session III: Heart Failure And Its Economics In Asia

Heart Failure in Asia – Prevalence, Disease Severity & Economic Impact

Focus on Clinical Trials: The Changing and Challenging Trend of Asian Involvement

Panel Q&A Session

Coffee/ Tea Break

Session IV: Advances and Future Prospects

Treatment of Chronic Heart Failure: Clinical Trial Update and Pipeline

LDL Cholesterol & In�ammation: Controversies and Future Therapeutic Directions

Panel Q&A Session

Dinner

TIME SESSION Prof Dr John JV McMurray

Dr John JV McMurray is a Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK. He has also served as a distinguished member of the European Society of Cardiology (ESC) faculty, and has chaired several guideline committees, including the 2012 ESC Heart Failure Guidelines task force. Professor McMurray is a member of the editorial board of the New England Journal of Medicine and several other leading cardiovascular journals, including the European Heart Journal and Circulation. He is recognized as being one of the most in�uential biomedical researchers in the world owing to his many high-pro�le clinical trials in heart failure, coronary heart disease, atrial �brillation, and diabetes.

Prof Dr Michael Böhm

Dr Michael Böhm is a Professor of internal medicine and cardiology and director of internal medicine (cardiology, angiology, and intensive care medicine) at the University of Saarland, Homburg, Saarland, Germany. He has served as president of the German society of cardiology; and his special interests include the pathophysiology and therapy of heart failure. In particular, Prof Böhm has been involved in studies on signal transduction in the failing heart and in vascular biology. Professor Böhm has been the principal investigator in several international multicenter studies and has written more than 350 original papers, book chapters and review articles. He has obtained several awards from scienti�c societies, the most important being the Theodor Frerichs Award of the German Society of Internal Medicine, which he received in 1989 for the discovery of mechanisms in heart failure. Professor Böhm is a reviewer for most recognized scienti�c journals in the cardiovascular �eld and is a chief editor of the Clinical Research in Cardiology journal.

Dr Bernard Kwok

Dr Bernard Kwok is Singapore's �rst quali�ed transplant cardiologist, and he established Singapore's �rst multidisciplinary Heart Failure Programme at the National Heart Centre of Singapore (NHCS). He was the Director of the Programme, and continues to care for patients with advanced heart failure and heart transplant recipients as a Visiting Consultant at the NHCS. Dr Kwok is a Clinical Senior Lecturer in the Yong Loo Lin school of Medicine at the National University of Singapore and has previously served as the Governor of the Singapore Chapter of the American College of Cardiology. He was formerly the President of the Singapore Cardiac Society and is the founding President of the Heart Failure Society (Singapore).

Dr Pardeep S Jhund

Dr Pardeep Jhund is a Clinical Senior Lecturer at the University of Glasgow and Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital. His research interests include the epidemiology and co-morbidities associated with heart failure. He also uses clinical trial data sets to further understand the complex syndrome of heart failure. Dr Jhund has extensive experience in the design and conduct of clinical trials through his involvement in a number of multinational randomised trials as an investigator and as a member of clinical endpoint committees. A widely published author, he has published over 70 papers in high impact factor cardiovascular journals.

Dr David Sim Kheng Leng

Adjunct Assistant Professor David Sim is a Senior Consultant with the Department of Cardiology and Director of the Heart Failure Programme at the National Heart Centre Singapore (NHCS). He is chairman of the NHCS Heart Failure Coordinated Care Pathway Committee and has previously served as a member of the Singapore Heart Failure Guidelines Committee in 2014. Dr David Sim has lectured widely on the topic of Heart Failure at both the national and international levels; drawing on his substantial experience as a principal investigator in several large, multinational industry-sponsored trials as well as academic trials. He has published extensively in the area of Heart Failure and interventional cardiology, and his stable of original papers includes tier-one journals.

INTERNATIONAL FACULTY